首页|期刊导航|癌症生物学与医学（英文版）|Advances in antibody-drug conjugates for urothelial carcinoma treatment

Advances in antibody-drug conjugates for urothelial carcinoma treatment

Jinchang Wei Bixia Tang Xieqiao Yan Juan Li Li Zhou Siming Li Huayan Xu Xinan Sheng

癌症生物学与医学（英文版）2025，Vol.22Issue(10)：1132-1142,11.

癌症生物学与医学（英文版）2025，Vol.22Issue(10)：1132-1142,11.DOI:10.20892/j.issn.2095-3941.2025.0284

Advances in antibody-drug conjugates for urothelial carcinoma treatment

Jinchang Wei ¹Bixia Tang ²Xieqiao Yan ¹Juan Li ¹Li Zhou ¹Siming Li ¹Huayan Xu ¹Xinan Sheng¹

作者信息

1. Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Genitourinary Oncology,Peking University Cancer Hospital & Institute,Beijing 100142,China
2. Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Melanoma and Sarcoma,Peking University Cancer Hospital & Institute,Beijing 100142,China
折叠

摘要

引用本文复制引用

Jinchang Wei,Bixia Tang,Xieqiao Yan,Juan Li,Li Zhou,Siming Li,Huayan Xu,Xinan Sheng..Advances in antibody-drug conjugates for urothelial carcinoma treatment[J].癌症生物学与医学（英文版）,2025,22(10):1132-1142,11.

基金项目

This study was supported by the Beijing Natural Science Foundation(Grant No.L244024),National Natural Science Foundation of China(Grant Nos.82172604 and 82473199),and CSCO Clinical Oncology Research Foundation(Grant No.Y-2022HER2AZMS-0258). （Grant No.L244024）

癌症生物学与医学（英文版）

ISSN：2095-3941

访问量0

下载量0

段落导航